Clinical Trial Update: Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Nitrocamptothecin with Gemcitabine for unresectable locally advanced or metastatic pancreatic cancer; the current status is lis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nitrocamptothecin (nitrocamptothecin)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Pancreatic Cancer | Phase 3 | Status: UNKNOWN